Abstract: The future evaluation device includes a visit detection unit that detects departure facilities of a plurality of moving objects and a visit to a facility different from each departure facility, a map information storage unit that stores facility information including category information and location information on a facility, a comparative data information storage unit that stores, for the facility different from each departure facility, the number of previous visits of each moving object to the facility according to the category of departure facility as comparative data information, a prediction condition receiving unit that receives, as a user-specified facility, information on a facility specified by a user from the facility information, and an evaluation unit that creates predictive index information on the future of the user-specified facility from a proportion change based on comparison between the number of visits according to the category of departure facility and the comparative data information.

Abstract: A change in usage mode of a facility is detected. An information analysis device (1) includes a visit pattern information creation section (112) which creates visit pattern information related to a facility from vehicle information from a plurality of vehicles and a transition in successive positional information, and creates visit vehicle information related to the facility by cumulating vehicles parked in a parking lot of the facility for every vehicle information; a visit pattern change determination section (113) which determines whether both a change amount after a predetermined time period of the visit pattern information and a change amount after a predetermined time period of the visit vehicle information have changed; and a facility change information creation section (114) which creates facility change information indicating a change in facility information.

Abstract: An information analysis device includes: a visit pattern information creation section that creates first visit pattern information related to a facility by cumulating a number of vehicle for every time slot in which parking was started in a parking lot of the facility from a transition in successive positional information from a plurality of vehicles, and further creates second visit pattern information related to the facility differing from the first visit pattern information, from a transition in the successive positional information from the plurality of vehicles; a visit pattern change determination section which determines whether both a change amount after a predetermined period in the first visit pattern information and a change amount after a predetermined period in the second visit pattern information have changed; and a facility change information creation section which creates facility change information indicating a change in the facility information when a change was determined.

Abstract: An object of the present invention is to provide a compound with a high refractive index and a low extinction coefficient at a wavelength in range of 450 nm to 750 nm in a capping layer to improve light extraction efficiency of an organic electroluminescent device. The present invention was achieved by focusing on the fact that a specific arylamine based compound has excellent thin film stability and durability and is able improve the refractive index by adjusting the molecular structures, and planning molecule, and an organic electroluminescent device having excellent luminous efficiency was obtained by using this compound as a material for constituting a capping layer.

Abstract: It is an object of the present invention to provide a compound for a capping layer that has a high refractive index and a low extinction coefficient in a range of 450 nm to 750 nm to improve the light extraction efficiency of an organic EL element. The present invention has focused on the fact that compounds having a benzene skeleton at the center thereof are excellent in stability and also durability in the form of a thin film, and that the refractive index thereof can be improved by modifying the molecular structure, and thus, molecules have been designed. Provided is a compound represented by a general formula (1), and an organic EL element with excellent luminance efficiency is obtained by using that compound as a constituent material of a capping layer.

Abstract: To provide a variable axle driving device which can obtain a high deceleration ratio, and which can prevent noise from being easily generated. Provided is an axle driving device which includes a planet gear mechanism. The planet gear mechanism includes first planetary gears, second planetary gears, first stepped gears, and second stepped gears. A driving force is input into a larger gear of each first stepped gear. A smaller gear of each first stepped gear is meshed with a larger gear of each second stepped gear. A smaller gear of each second stepped gear is connected to a first internal gear via the first planetary gear. A larger gear of each second stepped gear is connected to a second internal gear via a second planetary gear.

Abstract: It is an object to provide an axle driving device that can change a deceleration ratio while obtaining a high deceleration ratio, and reduces noise during operation to have high ease of assembly and coolability. A carrier of a planet gear mechanism includes a first plate-like member, a second plate-like member, and a third plate-like member, and the third plate-like member includes the plate-like portion and the second plate-like member, a plurality of stays extended from the plate-like portion and connected to the first plate-like member, and a plurality of stays extended from the plate-like portion and connected to the second plate-like member.

Abstract: Phenyldifluoromethyl-substituted prolinamide compounds that have a cathepsin S inhibitory effect, and are usable as active ingredients of pharmaceutical compositions for preventing and/or treating autoimmune diseases including systemic lupus erythematosus (SLE) and lupus nephritis, allergies, or graft rejection of an organ, bone marrow or tissue.

Abstract: To provide a variable axle driving device which can obtain a high deceleration ratio, and which can prevent noise from being easily generated. Provided is an axle driving device which includes a planet gear mechanism. The planet gear mechanism includes first planetary gears, second planetary gears, first stepped gears, and second stepped gears. A driving force is input into a larger gear of each first stepped gear. A smaller gear of each first stepped gear is meshed with a larger gear of each second stepped gear. A smaller gear of each second stepped gear is connected to a first internal gear via the first planetary gear. A larger gear of each second stepped gear is connected to a second internal gear via a second planetary gear.

Abstract: It is an object to provide an axle driving device that can change a deceleration ratio while obtaining a high deceleration ratio, and reduces noise during operation to have high ease of assembly and coolability. A carrier of a planet gear mechanism includes a first plate-like member, a second plate-like member, and a third plate-like member, and the third plate-like member includes the plate-like portion and the second plate-like member, a plurality of stays extended from the plate-like portion and connected to the first plate-like member, and a plurality of stays extended from the plate-like portion and connected to the second plate-like member.

Abstract: Phenyldifluoromethyl-substituted prolinamide compounds that have a cathepsin S inhibitory effect, and are usable as active ingredients of pharmaceutical compositions for preventing and/or treating autoimmune diseases including systemic lupus erythematosus (SLE) and lupus nephritis, allergies, or graft rejection of an organ, bone marrow or tissue.

Abstract: Phenyldifluoromethyl-substituted prolinamide compounds that have a cathepsin S inhibitory effect, and are usable as active ingredients of pharmaceutical compositions for preventing and/or treating autoimmune diseases including systemic lupus erythematosus (SLE) and lupus nephritis, allergies, or graft rejection of an organ, bone marrow or tissue.

Abstract: [Problem] To provide a compound useful as a cathepsin S inhibitor. [Means for Solution] The present inventors have examined a compound that has a cathepsin S inhibitory effect and is usable as an active ingredient of a pharmaceutical composition for preventing and/or treating autoimmune disease including systemic lupus erythematosus (SLE) and lupus nephritis, allergies, or graft rejection of an organ, bone marrow or tissue, and have found that a phenyldifluoromethyl-substituted prolinamide compound of the present invention has the cathepsin S inhibitory effect, thereby completing the present invention. The phenyldifluoromethyl-substituted prolinamide compound of the present invention has the cathepsin S inhibitory effect and is useful as an agent for preventing and/or treating autoimmune disease including SLE and nephritis, allergies, or graft rejection of an organ, bone marrow or tissue.